Table 1.
Patient characteristics of the gout cohort
| Characteristics | Gout cohort (N = 75) | Control group (N = 30) |
|---|---|---|
| Sex (male), n (%) | 68 (89.5) | 14 (46.7) |
| Age, mean (s.d.), years | 58 (11.7) | 49 (15.2) |
| Disease duration, median (IQR), years | 4 (2–10) | N.A. |
| Mono-articular gout, n (%) | 22 (29) | N.A. |
| Polyarticular gout, n (%) | 53 (71) | N.A. |
| Subcutaneous tophaceous gout, n (%) | 22 (29) | N.A. |
| VAS pain, median (IQR) | 11 (1–45) | N.A. |
| VAS disease activity, median (IQR) | 19 (1–48.5) | N.A. |
| Serum urate, mean (s.d.), mmol/l | 0.42 (0.09) | N.D. |
| Systolic blood pressure, mean (s.d.), mmHg | 142 (17.1) | 125 (16.6) |
| Smoking, yes, n (%) | 13 (17.1) | 5 (17) |
| BMI, mean (s.d.), kg/m2 | 30.4 (4.9) | 24.1 (3.2) |
| Total cholesterol, mean (s.d.), mmol/l | 5.1 (1.2) | 5.5 (1.1) |
| Triglycerides, mean (s.d.), mmol/l | 2.4 (1.8) | N.D. |
| LDL cholesterol, mean (s.d.), mmol/l | 3.3 (1.0) | 3.2 (0.9) |
| HDL cholesterol, mean (s.d.), mmol/l | 1.3 (0.5) | 1.9 (0.5) |
| Cholesterol ratio (total:HDL), mean (s.d.) | 4.4 (1.5) | 3.0 (1.0) |
N.A., not applicable; N.D., not determined; VAS, visual analogue scale.